BOSTON (AP) — BOSTON (AP) — Elicio Therapeutics, Inc. (ELTX) on Monday reported a loss of $11.8 million in its first quarter.

On a per-share basis, the Boston-based company said it had a loss of 65 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ELTX at https://www.zacks.com/ap/ELTX